Roger Medel MD - 30 Dec 2021 Form 4 Insider Report for MEDNAX, INC. (MD)

Role: Director
Signature: /s/ Dominic J. Andreano, Attorney-in-Fact
Issuer symbol: MD
Transactions as of: 30 Dec 2021
Net transactions value: -$1,234,344
Form type: 4
Filing time: 30 Dec 2021, 16:13:11 UTC
Previous filing: 29 Dec 2021
Next filing: 04 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Sale	$1,234,344	-45,397	-4.6%	$27.19	946,014	30 Dec 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.
F2	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.96 to $27.64 for a weighted average sales price of $27.19. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.96 to $27.64 for a weighted average sales price of $27.19. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.